Sara Tous Belmonte
Sara Tous holds a Technical degree in Statistics from the Polytechnic University of Catalonia (UPC, 2001) and a Bachelor’s degree in Science and Statistical techniques (UPC, 2008).
From 2001 to 2003, she worked as data manager in the Quality Control Department of the Catalan Centre of Innovation and Business Development in the Government of Catalonia.
In 2005 she joined the Infections and Cancer Unit in the Cancer Epidemiology Research Programme (PREC) as a statistician. Over the last 16 years, she has been involved in the study of the relationship between HPV and anogenital and head and neck cancers. She is responsible for the statistical analysis of the different projects.
Sara Tous is co-author of more than 30 peer-reviewed scientific publications, and she is a member of different groups supporting research on HPV and related genital and head and neck cancers, such as AGAUR and CIBERESP (a network of different research groups from Spain devoted to solving public health issues). Since 2014 she is also a member of the Statistics Catalan Society; there she is involved in several dissemination activities about statistics among secondary school students.
Pimenoff VN, Tous S, Benavente Y, et al. Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: results from a worldwide cross-sectional study. Int J Cancer. 2018 Nov 2. doi: 10.1002/ijc.31964.
Fernández-Montolí ME, Tous S, et al. Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2-3 after treatment with a large loop excision of the transformation zone: a retrospective study. BJOG. 2020 Feb;127(3):377-387. doi: 10.1111/1471-0528.15996.
Mena M, Frias-Gomez J, Taberna M, (…), Tous S, et al. Epidemiology of human papillomavirus-related oropharyngeal cancer in a classically low-burden region of southern Europe. Sci Resp. 2020 Aug 6;10(1): 13219. doi: 10.1038/s41598-020-70118-7.
Mena M, Taberna M, Tous S, et al. Double positivity for HPV-DNA/p16(ink4a) is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients. Oral Oncol. 2018 Mar;78:137-144. doi: 10.1016/j.oraloncology.2018.01.010.
Mena M, Lloveras B, Tous S, et al. Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study. PLoS One. 2017 Oct 16;12(10):e0184520. doi: 10.1371/journal.pone.0184520.
Gheit T, Anantharaman D, Holzinger D, (…), Tous S, et al. Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India. Int J Cancer. 2017 Jul 1;141(1):143-151. doi: 10.1002/ijc.30712.
de Sanjosé S, Serrano B, Tous S, et al. Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58. JNCI Cancer Spectr. 2019 Jan 7;2(4):pky045 doi: 10.1093/jncics/pky045.
Castellsagué X, Alemany L, Quer M, (…), Tous S, et al. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients. J Natl Cancer Inst. 2016 Jan 28;108(6):djv403. doi: 10.1093/jnci/djv403.
Alemany L, Cubilla A, Halec G, (…), Tous S, et al. Role of Human Papillomavirus in Penile Carcinomas Worldwide. Eur Urol. 2016 May;69(5):953-61. doi: 10.1016/j.eururo.2015.12.007.
de Sanjose S, Quint WG, Alemany L, (…), Tous S, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010 Nov;11(11):1048-56. doi: 10.1016/S1470-2045(10)70230-8.